Literature DB >> 19098316

Purification and characterization of mouse lacrimal gland epithelial cells and reconstruction of an acinarlike structure in three-dimensional culture.

Yoshiaki Ueda1, Yoko Karasawa, Yasushi Satoh, Shimpei Nishikawa, Junko Imaki, Masataka Ito.   

Abstract

PURPOSE: To clarify which factors are involved in postnatal lacrimal gland development, the expressions of several growth factors and their receptors were analyzed in purified lacrimal gland epithelial and mesenchymal cells. Reconstruction of acinarlike structures in three-dimensional culture conditions from this epithelial cell population was attempted.
METHODS: Lacrimal gland epithelial and mesenchymal cells were isolated from newborn mice and purified using nylon mesh and collagenase. By real-time reverse transcription-polymerase chain reaction, immunocytochemistry, and Western blotting, the expressions of several growth factors and their receptors were analyzed. Responses of epithelial cells to the growth factors were analyzed by the addition of these factors to the culture medium.
RESULTS: Fibroblast growth factor (FGF)10 and hepatocyte growth factor (HGF) were more intensely expressed in mesenchymal cells than in epithelial cells, and their receptors (FGFR2IIIb and c-Met, respectively) were less intensely expressed, whereas the expression of epidermal growth factor (EGF) and its receptor showed no significant difference between cell types. In the monolayer culture, cell viability was activated by the addition of EGF or HGF to epithelial cells, but no response was observed when FGF10 was added. The epithelial cells formed clusters with lumina when cultured on basement membrane matrix. These clusters contained secretion granules and showed positive immunostaining for aquaporin-5.
CONCLUSIONS: EGF and HGF were considered to act in an autocrine/paracrine manner in and around the postnatal lacrimal gland, whereas epithelial cells did not respond to FGF10. It was suggested that certain extracellular matrix conditions accommodate these epithelial cells to reconstruct functional acinarlike structures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19098316     DOI: 10.1167/iovs.08-2503

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  7 in total

Review 1.  Lacrimal gland development: From signaling interactions to regenerative medicine.

Authors:  Ankur Garg; Xin Zhang
Journal:  Dev Dyn       Date:  2017-08-18       Impact factor: 3.780

2.  Strategies for Regenerating the Lacrimal Gland.

Authors:  Catherine Y Liu; Masatoshi Hirayama; Marwan Ali; Dhara Shah; Vinay K Aakalu
Journal:  Curr Ophthalmol Rep       Date:  2017-05-29

3.  Characterization of cultivated murine lacrimal gland epithelial cells.

Authors:  Shinya Kobayashi; Tetsuya Kawakita; Motoko Kawashima; Naoko Okada; Kenji Mishima; Ichiro Saito; Masataka Ito; Shigeto Shimmura; Kazuo Tsubota
Journal:  Mol Vis       Date:  2012-05-12       Impact factor: 2.367

4.  Establishing human lacrimal gland cultures with secretory function.

Authors:  Shubha Tiwari; Mohammad Javed Ali; Murali M S Balla; Milind N Naik; Santosh G Honavar; Vijay Anand P Reddy; Geeta K Vemuganti
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

5.  Molecular Profiling of the Developing Lacrimal Gland Reveals Putative Role of Notch Signaling in Branching Morphogenesis.

Authors:  Galina Dvoriantchikova; Wensi Tao; Steve Pappas; Gabriel Gaidosh; David T Tse; Dmitry Ivanov; Daniel Pelaez
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-02-01       Impact factor: 4.799

Review 6.  Autoimmune Epithelitis and Chronic Inflammation in Sjögren's Syndrome-Related Dry Eye Disease.

Authors:  Yoko Ogawa; Tsutomu Takeuchi; Kazuo Tsubota
Journal:  Int J Mol Sci       Date:  2021-10-30       Impact factor: 5.923

Review 7.  Current approaches for the regeneration and reconstruction of ocular surface in dry eye.

Authors:  Vimal Kishor Singh; Pallavi Sharma; Uttkarsh Kumar Sharma Vaksh; Ramesh Chandra
Journal:  Front Med (Lausanne)       Date:  2022-09-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.